BCM
CORZ

Bayesian Capital Management’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Bayesian Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,600
Closed -$1.62K – 1188
2022
Q4 		$1.62K Sell
21,600
-9,700
-31% -$4.45K ﹤0.01% 741
2022
Q3 		$41K Buy
+31,300
New +$66.6K 0.01% 632

Other funds holding CORZ

SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
CWC
Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return
BWP
BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Bayesian Capital Management's CORZ Position: Q1 2023 in Review

Bayesian Capital Management sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 21,600 shares — an estimated $1.62K sold.

Bayesian Capital Management first reported a position in CORZ in Q3 2022 and held it in 2 quarters. The position peaked at $41K in Q3 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

  • Bayesian Capital Management reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 21,600 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $1.62K.
  • Bayesian Capital Management first reported a position in Core Scientific, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Core Scientific, Inc. Common Stock position peaked at $41K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.